Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950123-11-028238
Filing Date
2011-03-23
Accepted
2011-03-23 16:05:16
Documents
2
Period of Report
2011-03-17
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A y04677e8vkza.htm 8-K/A 9557
2 EX-5.1 y04677exv5w1.htm EX-5.1 6680
  Complete submission text file 0000950123-11-028238.txt   17537
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33357 | Film No.: 11706566
SIC: 2836 Biological Products, (No Diagnostic Substances)